Systemic EBV1 T-cell lymphoma, if CD8 positive

Clinical trials for Systemic EBV1 T-cell lymphoma, if CD8 positive explained in plain language.

Never miss a new study

Get alerted when new Systemic EBV1 T-cell lymphoma, if CD8 positive trials appear

Sign up with your email to follow new studies for Systemic EBV1 T-cell lymphoma, if CD8 positive, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare blood cancers: first human trial launches

Disease control Recruiting now

This study tests a new drug called DR-01 in adults with rare types of leukemia or lymphoma. The goal is to see if it is safe and can shrink tumors. About 200 people will take part in this early-stage trial.

Matched conditions: SYSTEMIC EBV1 T-CELL LYMPHOMA, IF CD8 POSITIVE

Phase 1/2 • Sponsor: Dren Bio • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

Systemic EBV1 T-cell lymphoma, if CD8 positive

Get alerted when new Systemic EBV1 T-cell lymphoma, if CD8 positive trials appear

New hope for rare blood cancers: first human trial launches